Global Oral Antidiabetic (OAD) Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

September 2018 | 121 pages | ID: GF09411A126EN
GlobalInfoResearch

Abstracts

Diabetic is the condition where the sugar (glucose) level is high in the blood or the production of the insulin is inadequate. Diabetes main type the very first one is Type 1 and the second is Type 2, both the diabetic are most commonly find in the current scenario, apart from this many other diabetics case are also been listed as gestational diabetes and others. Various treatment method are present in the market injection, oral and others. The mostly used method of treatment or managing the diabetes is the oral.

Scope of the Report:

This report studies the Oral Antidiabetic (OAD) Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Oral Antidiabetic (OAD) Treatment market by product type and applications/end industries.

North America has the 44.3 million population with diabetes in 2015 according to the IDF, same as Europe have 59.8 million in 2015 according to IDF and Asia Pacific has 60% diabetic population as compared with world according to Asian Diabetes Prevention Initiative.

The global Oral Antidiabetic (OAD) Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Oral Antidiabetic (OAD) Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Pfizer
• Eli Lilly
• Merck
• Sanofi
• AstraZeneca
• Glenmark
• Novartis
• Boehringer Ingelheim
• Novo Nordisk
• Mannkind

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Market Segment by Type, covers

• Sulphonylureas
• Biguanides
• Intestinal α-Glucosidase Inhibitors
• Others

Market Segment by Applications, can be divided into

• Hospital
• Clinics
• Diabetics Treatment Centres
• Others
  
  

Contents

1 ORAL ANTIDIABETIC (OAD) TREATMENT MARKET OVERVIEW

1.1 Product Overview and Scope of Oral Antidiabetic (OAD) Treatment
1.2 Classification of Oral Antidiabetic (OAD) Treatment by Types
  1.2.1 Global Oral Antidiabetic (OAD) Treatment Revenue Comparison by Types (2017-2023)
  1.2.2 Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Types in 2017
  1.2.3 Sulphonylureas
  1.2.4 Biguanides
  1.2.5 Intestinal α-Glucosidase Inhibitors
  1.2.6 Others
1.3 Global Oral Antidiabetic (OAD) Treatment Market by Application
  1.3.1 Global Oral Antidiabetic (OAD) Treatment Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospital
  1.3.3 Clinics
  1.3.4 Diabetics Treatment Centres
  1.3.5 Others
1.4 Global Oral Antidiabetic (OAD) Treatment Market by Regions
  1.4.1 Global Oral Antidiabetic (OAD) Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Oral Antidiabetic (OAD) Treatment Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Oral Antidiabetic (OAD) Treatment Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oral Antidiabetic (OAD) Treatment Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Oral Antidiabetic (OAD) Treatment Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oral Antidiabetic (OAD) Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Oral Antidiabetic (OAD) Treatment (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Pfizer
  2.1.1 Business Overview
  2.1.2 Oral Antidiabetic (OAD) Treatment Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Pfizer Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eli Lilly
  2.2.1 Business Overview
  2.2.2 Oral Antidiabetic (OAD) Treatment Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Eli Lilly Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
  2.3.1 Business Overview
  2.3.2 Oral Antidiabetic (OAD) Treatment Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Merck Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi
  2.4.1 Business Overview
  2.4.2 Oral Antidiabetic (OAD) Treatment Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Sanofi Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 AstraZeneca
  2.5.1 Business Overview
  2.5.2 Oral Antidiabetic (OAD) Treatment Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 AstraZeneca Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Glenmark
  2.6.1 Business Overview
  2.6.2 Oral Antidiabetic (OAD) Treatment Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Glenmark Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novartis
  2.7.1 Business Overview
  2.7.2 Oral Antidiabetic (OAD) Treatment Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Novartis Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Boehringer Ingelheim
  2.8.1 Business Overview
  2.8.2 Oral Antidiabetic (OAD) Treatment Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 Novo Nordisk
  2.9.1 Business Overview
  2.9.2 Oral Antidiabetic (OAD) Treatment Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Novo Nordisk Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.10 Mannkind
  2.10.1 Business Overview
  2.10.2 Oral Antidiabetic (OAD) Treatment Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Mannkind Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL ORAL ANTIDIABETIC (OAD) TREATMENT MARKET COMPETITION, BY PLAYERS

3.1 Global Oral Antidiabetic (OAD) Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Oral Antidiabetic (OAD) Treatment Players Market Share
  3.2.2 Top 10 Oral Antidiabetic (OAD) Treatment Players Market Share
3.3 Market Competition Trend

4 GLOBAL ORAL ANTIDIABETIC (OAD) TREATMENT MARKET SIZE BY REGIONS

4.1 Global Oral Antidiabetic (OAD) Treatment Revenue and Market Share by Regions
4.2 North America Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA ORAL ANTIDIABETIC (OAD) TREATMENT REVENUE BY COUNTRIES

5.1 North America Oral Antidiabetic (OAD) Treatment Revenue by Countries (2013-2018)
5.2 USA Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)

6 EUROPE ORAL ANTIDIABETIC (OAD) TREATMENT REVENUE BY COUNTRIES

6.1 Europe Oral Antidiabetic (OAD) Treatment Revenue by Countries (2013-2018)
6.2 Germany Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
6.4 France Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC ORAL ANTIDIABETIC (OAD) TREATMENT REVENUE BY COUNTRIES

7.1 Asia-Pacific Oral Antidiabetic (OAD) Treatment Revenue by Countries (2013-2018)
7.2 China Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
7.5 India Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA ORAL ANTIDIABETIC (OAD) TREATMENT REVENUE BY COUNTRIES

8.1 South America Oral Antidiabetic (OAD) Treatment Revenue by Countries (2013-2018)
8.2 Brazil Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE ORAL ANTIDIABETIC (OAD) TREATMENT BY COUNTRIES

9.1 Middle East and Africa Oral Antidiabetic (OAD) Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)

10 GLOBAL ORAL ANTIDIABETIC (OAD) TREATMENT MARKET SEGMENT BY TYPE

10.1 Global Oral Antidiabetic (OAD) Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Oral Antidiabetic (OAD) Treatment Market Forecast by Type (2018-2023)
10.3 Sulphonylureas Revenue Growth Rate (2013-2023)
10.4 Biguanides Revenue Growth Rate (2013-2023)
10.5 Intestinal α-Glucosidase Inhibitors Revenue Growth Rate (2013-2023)
10.6 Others Revenue Growth Rate (2013-2023)

11 GLOBAL ORAL ANTIDIABETIC (OAD) TREATMENT MARKET SEGMENT BY APPLICATION

11.1 Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Application (2013-2018)
11.2 Oral Antidiabetic (OAD) Treatment Market Forecast by Application (2018-2023)
11.3 Hospital Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Diabetics Treatment Centres Revenue Growth (2013-2018)
11.6 Others Revenue Growth (2013-2018)

12 GLOBAL ORAL ANTIDIABETIC (OAD) TREATMENT MARKET SIZE FORECAST (2018-2023)

12.1 Global Oral Antidiabetic (OAD) Treatment Market Size Forecast (2018-2023)
12.2 Global Oral Antidiabetic (OAD) Treatment Market Forecast by Regions (2018-2023)
12.3 North America Oral Antidiabetic (OAD) Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Oral Antidiabetic (OAD) Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Oral Antidiabetic (OAD) Treatment Revenue Market Forecast (2018-2023)
12.6 South America Oral Antidiabetic (OAD) Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Oral Antidiabetic (OAD) Treatment Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Oral Antidiabetic (OAD) Treatment Picture
Table Product Specifications of Oral Antidiabetic (OAD) Treatment
Table Global Oral Antidiabetic (OAD) Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Types in 2017
Figure Sulphonylureas Picture
Figure Biguanides Picture
Figure Intestinal α-Glucosidase Inhibitors Picture
Figure Others Picture
Table Global Oral Antidiabetic (OAD) Treatment Revenue (Million USD) by Application (2013-2023)
Figure Oral Antidiabetic (OAD) Treatment Revenue Market Share by Applications in 2017
Figure Hospital Picture
Figure Clinics Picture
Figure Diabetics Treatment Centres Picture
Figure Others Picture
Table Global Market Oral Antidiabetic (OAD) Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Oral Antidiabetic (OAD) Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Oral Antidiabetic (OAD) Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Oral Antidiabetic (OAD) Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Oral Antidiabetic (OAD) Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Oral Antidiabetic (OAD) Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Oral Antidiabetic (OAD) Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Oral Antidiabetic (OAD) Treatment Type and Applications
Table Pfizer Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Oral Antidiabetic (OAD) Treatment Type and Applications
Table Eli Lilly Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Oral Antidiabetic (OAD) Treatment Type and Applications
Table Merck Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Oral Antidiabetic (OAD) Treatment Type and Applications
Table Sanofi Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Oral Antidiabetic (OAD) Treatment Type and Applications
Table AstraZeneca Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Glenmark Basic Information, Manufacturing Base and Competitors
Table Glenmark Oral Antidiabetic (OAD) Treatment Type and Applications
Table Glenmark Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Oral Antidiabetic (OAD) Treatment Type and Applications
Table Novartis Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Type and Applications
Table Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Oral Antidiabetic (OAD) Treatment Type and Applications
Table Novo Nordisk Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Mannkind Basic Information, Manufacturing Base and Competitors
Table Mannkind Oral Antidiabetic (OAD) Treatment Type and Applications
Table Mannkind Oral Antidiabetic (OAD) Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Oral Antidiabetic (OAD) Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Oral Antidiabetic (OAD) Treatment Revenue Share by Players (2013-2018)
Figure Global Oral Antidiabetic (OAD) Treatment Revenue Share by Players in 2016
Figure Global Oral Antidiabetic (OAD) Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Oral Antidiabetic (OAD) Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Oral Antidiabetic (OAD) Treatment Revenue Market Share in 2017
Figure Global Oral Antidiabetic (OAD) Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Oral Antidiabetic (OAD) Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Regions in 2017
Figure North America Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Figure South America Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Table North America Oral Antidiabetic (OAD) Treatment Revenue by Countries (2013-2018)
Table North America Oral Antidiabetic (OAD) Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Oral Antidiabetic (OAD) Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Oral Antidiabetic (OAD) Treatment Revenue Market Share by Countries in 2017
Figure USA Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Table Europe Oral Antidiabetic (OAD) Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Oral Antidiabetic (OAD) Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Oral Antidiabetic (OAD) Treatment Revenue Market Share by Countries in 2017
Figure Germany Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Figure UK Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Figure France Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Oral Antidiabetic (OAD) Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Oral Antidiabetic (OAD) Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Oral Antidiabetic (OAD) Treatment Revenue Market Share by Countries in 2017
Figure China Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Figure India Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Table South America Oral Antidiabetic (OAD) Treatment Revenue by Countries (2013-2018)
Table South America Oral Antidiabetic (OAD) Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Oral Antidiabetic (OAD) Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Oral Antidiabetic (OAD) Treatment Revenue Market Share by Countries in 2017
Figure Brazil Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Oral Antidiabetic (OAD) Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Oral Antidiabetic (OAD) Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Oral Antidiabetic (OAD) Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Oral Antidiabetic (OAD) Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Oral Antidiabetic (OAD) Treatment Revenue and Growth Rate (2013-2018)
Table Global Oral Antidiabetic (OAD) Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Oral Antidiabetic (OAD) Treatment Revenue Share by Type (2013-2018)
Figure Global Oral Antidiabetic (OAD) Treatment Revenue Share by Type (2013-2018)
Figure Global Oral Antidiabetic (OAD) Treatment Revenue Share by Type in 2017
Table Global Oral Antidiabetic (OAD) Treatment Revenue Forecast by Type (2018-2023)
Figure Global Oral Antidiabetic (OAD) Treatment Market Share Forecast by Type (2018-2023)
Figure Global Sulphonylureas Revenue Growth Rate (2013-2018)
Figure Global Biguanides Revenue Growth Rate (2013-2018)
Figure Global Intestinal α-Glucosidase Inhibitors Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Oral Antidiabetic (OAD) Treatment Revenue by Application (2013-2018)
Table Global Oral Antidiabetic (OAD) Treatment Revenue Share by Application (2013-2018)
Figure Global Oral Antidiabetic (OAD) Treatment Revenue Share by Application (2013-2018)
Figure Global Oral Antidiabetic (OAD) Treatment Revenue Share by Application in 2017
Table Global Oral Antidiabetic (OAD) Treatment Revenue Forecast by Application (2018-2023)
Figure Global Oral Antidiabetic (OAD) Treatment Market Share Forecast by Application (2018-2023)
Figure Global Hospital Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Diabetics Treatment Centres Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Oral Antidiabetic (OAD) Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Oral Antidiabetic (OAD) Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Oral Antidiabetic (OAD) Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Oral Antidiabetic (OAD) Treatment Revenue Market Forecast (2018-2023)
Figure Europe Oral Antidiabetic (OAD) Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Oral Antidiabetic (OAD) Treatment Revenue Market Forecast (2018-2023)
Figure South America Oral Antidiabetic (OAD) Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Oral Antidiabetic (OAD) Treatment Revenue Market Forecast (2018-2023)